CNCLARGE

Centene Corporation

HealthcareMedical - Healthcare Plans
$63.67
$0.00(+0.63%)
52W$25.08
$66.55
Updated Jun 22, 02:00 AM
RSI54
RS Rating92/99
Beta0.33
Volatility65%
F-Score6/9
Mkt Cap$31.4B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Centene Corporation is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 92), indicating clear outperformance against the broad market. Earnings growth of 18% provides fundamental context to the price action. Investors should exercise caution due to high volatility (65% annualized), which requires wider risk management.

Relative Strength
92
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
0.33
vs S&P 500
LOW VOL
52W Position
93%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$54.27
50 SMA > 100 SMA$46.57
100 SMA > 150 SMA$44.72
150 SMA > 200 SMA$42.21

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$61.78+3.06%ABOVE
50 SMA$54.27+17.33%ABOVE
100 SMA$46.57+36.72%ABOVE
150 SMA$44.72+42.36%ABOVE
200 SMA$42.21+50.83%ABOVE

Price Performance

1D+0.6%
1W-3.9%
1M+4.8%
3M+68.8%
6M+55.6%
YTD+46.1%
1Y+10.6%
3Y-2.5%
52-Week Trading Range93% from low
$63.67
52W Low$25.08
52W High$66.55

Technical Indicators

RSI (14)NEUTRAL
54.1
305070
Setup ScoreCOOL
3/10
Base depth: 57.2%

Risk Profile

Beta
0.33
52W Vol
65%
ATR
$2.64
Max DD (1Y)
-55%

Volume Analysis

Today
4.83M
50D Avg
5.15M
Vol Ratio
0.94x
Liquidity
LIQUID

Earnings Momentum

Q2'25-124%
$-0.51
Q3'25-1093%
$-13.50
Q4'25-500%
$-2.24
Q1'26+18%
$3.11
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+23.95%
5 Years:+11.88%
3 Years:+10.45%
TTM:+17.02%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-295.83%

Stock Price CAGR

10 Years:+5.83%
5 Years:-3.17%
3 Years:-2.54%
1 Year:+10.64%

Return on Equity

10Y Avg:6.1%
5Y Avg:0.9%
3Y Avg:-1.8%
Last Year:-28.6%

Key Metrics

Market Cap$31.4B
Gross Margin12.2%
Net Margin-3.4%
Piotroski F-Score6/9

Frequently Asked Questions

Is CNC in an uptrend right now?

CNC has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, CNC is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is CNC overbought or oversold?

CNC's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.

Is CNC outperforming the market?

CNC has a Relative Strength (RS) Rating of 92 out of 99. Yes, CNC is a market leader, outperforming 92% of all stocks over the past 12 months.

Where is CNC in its 52-week range?

CNC is trading at $63.67, which is 96% of its 52-week high ($66.55) and 93% above its 52-week low ($25.08).

How volatile is CNC?

CNC has a Beta of 0.33 and 52-week volatility of 65%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.